切换至 "中华医学电子期刊资源库"

中华诊断学电子杂志 ›› 2022, Vol. 10 ›› Issue (03) : 152 -157. doi: 10.3877/cma.j.issn.2095-655X.2022.03.002

内分泌代谢性疾病诊治

体检人群甘油三酯葡萄糖指数对非酒精性脂肪性肝病发病风险的诊断价值
张梅玉1, 吴胜利2, 向蔚婷2, 孙克红1, 李农2,()   
  1. 1. 834000 克拉玛依市中西医结合医院(市人民医院)健康管理体检中心
    2. 834000 克拉玛依市中西医结合医院(市人民医院)内分泌代谢中心
  • 收稿日期:2021-08-16 出版日期:2022-08-26
  • 通信作者: 李农
  • 基金资助:
    国家重点研发计划重点专项(2018YFC1311800)

The diagnostic value of the triglyceride-glucose index in predicting the risk of non-alcoholic fatty liver disease in physical examination population

Meiyu Zhang1, Shengli Wu2, Weiting Xiang2, Kehong Sun1, Nong Li2,()   

  1. 1. Health Management and Physical Examination Center, Karamay Integrated Chinese and Western Hospital (Municipal People′s Hospital), Karamay 834000, China
    2. Endocrine Metabolic Center, Karamay Integrated Chinese and Western Hospital (Municipal People′s Hospital), Karamay 834000, China
  • Received:2021-08-16 Published:2022-08-26
  • Corresponding author: Nong Li
引用本文:

张梅玉, 吴胜利, 向蔚婷, 孙克红, 李农. 体检人群甘油三酯葡萄糖指数对非酒精性脂肪性肝病发病风险的诊断价值[J/OL]. 中华诊断学电子杂志, 2022, 10(03): 152-157.

Meiyu Zhang, Shengli Wu, Weiting Xiang, Kehong Sun, Nong Li. The diagnostic value of the triglyceride-glucose index in predicting the risk of non-alcoholic fatty liver disease in physical examination population[J/OL]. Chinese Journal of Diagnostics(Electronic Edition), 2022, 10(03): 152-157.

目的

探讨体检人群甘油三酯葡萄糖(TyG)指数对非酒精性脂肪性肝病(NAFLD)发病风险的诊断价值。

方法

选取2018年12月至2019年12月于克拉玛依市中西医结合医院(市人民医院)进行健康体检的新疆油田公司和西部钻探公司的8 860例企业职工作为研究对象。采集研究对象的一般临床资料、血液生化指标、超声检查结果等,并计算TyG指数。应用多因素Logistic回归,分析NAFLD的危险因素;并使用受试者工作特征(ROC)曲线分析TyG指数对NAFLD发病的预测价值。

结果

3 261例为NAFLD。多因素Logistic回归分析结果显示,TyG指数、年龄、收缩压、腰围和丙氨酸转氨酶是NAFLD的独立危险因素,OR值(95%CI)分别为3.294(2.933~3.699)、1.013(1.006~1.020)、1.007(1.001~1.012)、1.092(1.085~1.100)和1.029(1.026~1.033)(均P<0.05)。ROC曲线分析结果显示,TyG指数的曲线下面积为0.818,TyG指数诊断NAFLD的截断值为4.310。

结论

TyG指数能够较好预测NAFLD的发病风险,可作为筛查NAFLD高危人群的有效指标。

Objective

To explore the predictive value of triglyceride-glucose (TyG) index on the risk of non-alcoholic fatty liver disease (NAFLD) in physical examination population.

Methods

From December 2018 to December 2019, a total of 8 860 employees from Xinjiang Oilfield Company and Western Drilling Company who underwent physical examinations in the Karamay Integrated Chinese and Western Hospital (Municipal People′s Hospital) were chosen as the research subjects. The subjects′ general clinical data, blood biochemical indexes, and ultrasonic examination results were collected, and the TyG index was calculated. The risk factors for NAFLD were studied using multivariate logistic regression. The receiver operating characteristic (ROC) curve was used to assess the predictive value of the TyG index for NAFLD.

Results

NAFLD affected 3 261 patients. The TyG index, age, systolic blood pressure, abdominal girth, and alanine aminotransferase were found to be independent risk factors for NAFLD, with ORs of 3.294(2.933-3.699), 1.013(1.006-1.020), 1.007(1.001-1.012), 1.092(1.085-1.100), and 1.029(1.026-1.033)(all P<0.05). The area under the curve (AUC) of TyG index was 0.818 according to the ROC curve analysis, and the cut-off value of TyG index in diagnosing NAFLD was 4.310.

Conclusion

The TyG index can better predict NAFLD risk and be used as an effective indicator for screening NAFLD high-risk populations.

表1 NAFLD组与无NAFLD组人群一般资料比较
表2 非酒精性脂肪性肝病发病危险因素的Logistic回归分析
表3 TyG指数与非酒精性脂肪性肝病发病风险相关性的亚组Logistic回归分析结果
图1 甘油三酯葡萄糖指数诊断非酒精性脂肪性肝病的ROC曲线
表4 男性和女性TyG指数诊断非酒性脂肪性肝病的效能比较
[1]
Younossi ZMKoenig ABAbdelatif D,et al.Global epidemiology of nonalcoholic fatty liver disease:meta analytic assessment of prevalence,incidence,and outcomes[J].Hepatology201664(1):73-84.DOI:10.1002/hep.28431.
[2]
Zhu JZ, Zhou QY, Wwang YM, et al. Prevalence of fatty liver disease and the economy in China:a systematic review[J].World J Gastroenterol201521(18):5695-5706.DOI:10.3748/wjg.v21.i18.5695.
[3]
Buzzetti EPinzani MTsochatzis EA.The multiple-hit pathogenesis of non-alcoholic fatty liver disease(NAFLD)[J].Metabolism201665(8):1038-1048.DOI:10.1016/j.metabol.2015.12.012.
[4]
Makri EGoulas APolyzos SA.Epidemiology,pathogenesis,diagnosis and emerging treatment of nonalcoholic fatty liver disease[J].Arch Med Res202152(1):25-37.DOI:10.1016/j.arcmed.2020.11.010.
[5]
Cobbina EAkhlaghi F.Non-alcoholic fatty liver disease(NAFLD)-pathogenesis,classification,and effect on drug metabolizing enzymes and transporters[J].Drug Metab Rev201749(2):197-211.DOI:10.1080/03602532.2017.1293683.
[6]
Guerrero-Romero FSimental-Mendia LEGonzález-Ortiz M,et al.The product of triglycerides and glucose,a simple measure of insulin sensitivity.Comparison with the euglycemic-hyperinsulinemic clamp[J].J Clin Endocrinol Metab201095(7):3347-3351.DOI:10.1210/jc.2010-0288.
[7]
Vasques AC, Novaes FS, de Oliveira Mda S, et al. TyG index performs better than HOMA in a Brazilian population:a hyperglycemic clamp validated study[J].Diabetes Res Clin Pract201193(3):e98-e100.DOI:10.1016/j.diabres.2011.05.030.
[8]
Khan SHSobia FNiazi NK, et al.Metabolic clustering of risk factors:evaluation of Triglyceride-glucose index (TyG index) for evaluation of insulin resistance[J].Diabetol Metab Syndr2018(10):74.DOI:10.1186/s13098-018-0376-8.
[9]
Song KPark GLee HS,et al.Prediction of insulin resistance by modified triglyceride glucose indices in youth[J].Life (Basel)202111(4):286.DOI:10.3390/life11040286.
[10]
中华医学会肝病学分会脂肪肝和酒精性肝病学组,中国医师协会脂肪性肝病专家委员会.非酒精性脂肪性肝病防治指南(2018年更新版)[J].实用肝脏病杂志201821(2):177-186.DOI:10.3969/j.issn.1672-5069.2018.02.007.
[11]
Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of nonalcoholic fatty liver disease:practice guidance from the American Association for the Study of Liver Diseases[J].Hepatology201867(1):328-357.DOI:10.1002/hep.29367.
[12]
Wang XJMalhi H.Nonalcoholic fatty liver disease[J].Ann Intern Med2018169(9):ITC65-ITC80.DOI:10.7326/AITC201811060.
[13]
Khan RSBril FCusi K,et al.Modulation of insulin resistance in nonalcoholic fatty liver disease[J].Hepatology201970(2):711-724.DOI:10.1002/hep.30429.
[14]
吴挺丰,廖献花,钟碧慧.中国部分地区非酒精性脂肪性肝病的流行情况[J].临床肝胆病杂志202036(6):1370-1373.DOI:10.3969/j.issn.1001-5256.2020.06.039.
[15]
齐婷,黎国红,程文强,等.非酒精性脂肪肝病相关危险因素与代谢综合征的关系研究[J/CD].中华诊断学电子杂志20153(3):204-207.DOI:10.3877/cma.j.issn.2095-655X.2015.03.014.
[16]
Kitae AHashimoto YHamaguchi M,et al.The triglyceride and glucose index is a predictor of incident nonalcoholic fatty liver disease:a population-based cohort study[J].Can J Gastroenterol Hepatol2019(2019):5121574.DOI:10.1155/2019/5121574.
[17]
Simental-Mendía LESimental-Mendía ERodríguez-Hernández H,et al.The product of triglycerides and glucose as biomarker for screening simple steatosis and NASH in asymptomatic women[J].Ann Hepatol201615(5):715-720.DOI:10.5604/16652681.1212431.
[18]
Zheng RDu ZWang M,et al.A longitudinal epidemiological study on the triglyceride and glucose index and the incident nonalcoholic fatty liver disease[J].Lipids Health Dis201817(1):262.DOI:10.1186/s12944-018-0913-3.
[19]
Zhang SDu TZhang J,et al.The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease[J].Lipids Health Dis201716(1):15.DOI:10.1186/s12944-017-0409-6.
[20]
Lee SBKim MKKang S,et al.Triglyceride glucose index is superior to the homeostasis model assessment of insulin resistance for predicting nonalcoholic fatty liver disease in Korean adults[J].Endocrinol Metab (Seoul)201934(2):179-186.DOI:10.3803/EnM.2019.34.2.179.
[21]
Huanan C, Sangsang L, Amoah AN, et al. Relationship between triglyceride glucose index and the incidence of non-alcoholic fatty liver disease in the elderly:a retrospective cohort study in China[J].BMJ Open202010(11):e039804.DOI:10.1136/bmjopen-2020-039804.
[22]
Ye Q, Zou B, Yeo YH, et al. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease:a systematic review and meta-analysis[J].Lancet Gastroenterol Hepatol20205(8):739-752.DOI:10.1016/S2468-1253(20)30077-7.
[23]
Shi Y, Wang Q, Sun Y, et al. The prevalence of lean/nonobese nonalcoholic fatty liver disease:a systematic review and meta-analysis[J].J Clin Gastroenterol202054(4):378-387.DOI:10.1097/MCG.0000000000001270 .
[24]
Alam SEslam MSkm Hasan N,et al.Risk factors of nonalcoholic fatty liver disease in lean body mass population:a systematic review and meta-analysis[J].JGH Open20215(11):1236-1249.DOI:10.1002/jgh3.12658.
[1] 郝玥萦, 毛盈譞, 张羽, 汪佳旭, 韩林霖, 匡雯雯, 孟瑶, 杨秀华. 超声引导衰减参数成像评估肝脂肪变性及其对心血管疾病风险的预测价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(08): 770-777.
[2] 洪玮, 叶细容, 刘枝红, 杨银凤, 吕志红. 超声影像组学联合临床病理特征预测乳腺癌新辅助化疗完全病理缓解的价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 571-579.
[3] 朱文婷, 顾鹏, 孙星. 非酒精性脂肪性肝病对乳腺癌发生发展及治疗的影响[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 371-375.
[4] 李霞林, 贺芳. 产后出血风险评估和早期预警系统[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 498-503.
[5] 奚玲, 仝瀚文, 缪骥, 毛永欢, 沈晓菲, 杜峻峰, 刘晔. 基于肌少症构建的造口旁疝危险因素预测模型[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 48-51.
[6] 屈勤芳, 束方莲. 盆腔器官脱垂患者盆底重建手术后压力性尿失禁发生的影响因素及列线图预测模型构建[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 606-612.
[7] 公宇, 廖媛, 尚梅. 肝细胞癌TACE术后复发影响因素及预测模型建立[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 818-824.
[8] 何慧玲, 鲁祖斌, 冯嘉莉, 梁声强. 术前外周血NLR和PLR对结肠癌术后肝转移的影响[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 682-687.
[9] 王贝贝, 崔振义, 王静, 王晗妍, 吕红芝, 李秀婷. 老年股骨粗隆间骨折患者术后贫血预测模型的构建与验证[J/OL]. 中华老年骨科与康复电子杂志, 2024, 10(06): 355-362.
[10] 孙晗, 于冰, 武侠, 周熙朗. 基于循环肿瘤DNA 甲基化的结直肠癌筛查预测模型的构建与验证[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 500-506.
[11] 韦巧玲, 黄妍, 赵昌, 宋庆峰, 陈祖毅, 黄莹, 蒙嫦, 黄靖. 肝癌微波消融术后中重度疼痛风险预测列线图模型构建及验证[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 715-721.
[12] 蔡晓雯, 李慧景, 丘婕, 杨翼帆, 吴素贤, 林玉彤, 何秋娜. 肝癌患者肝动脉化疗栓塞术后疼痛风险预测模型的构建及验证[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 722-728.
[13] 王誉英, 刘世伟, 王睿, 曾娅玲, 涂禧慧, 张蒲蓉. 老年乳腺癌新辅助治疗病理完全缓解的预测因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 641-646.
[14] 董晟, 郎胜坤, 葛新, 孙少君, 薛明宇. 反向休克指数乘以格拉斯哥昏迷评分对老年严重创伤患者发生急性创伤性凝血功能障碍的预测价值[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 541-547.
[15] 黄圣楷, 许斌, 苏健, 孙龙. 海南省2010~2020年乙型肝炎流行趋势的时间序列分析及预测[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 555-561.
阅读次数
全文


摘要